Author Archives: Kevin Frankowski

We are excited to have Hannuo Xie join the research group from this year’s Chemical Biology and Medicinal Chemistry graduate student class. Hannuo will be extending our efforts on D1 dopamine receptor positive allosteric modulators in new directions. Welcome, Han!

The group welcomes second-year CBMC graduate student Christiana Nnabuife to the team working on selective anti-metastasis therapeutic development.

We are excited to share that our work to develop and characterize pyrrole-based positive allosteric modulator (PAM)-antagonists of the D3 dopamine receptor has been published in The Journal of Medicinal Chemistry. Group members Feijun Wang, Amber Kelley and Disha Ghandi … Read more

Afnan was selected as a UNC Chemical Biology Interface Training Program fellow! The program provides support, cross-disciplinary training and professional development activities.

We’re thrilled to have Logan Zwerneman join the team as a post-doctoral scholar. Logan is a recent graduate of the UNC Chemistry Department and will add his talents toward the development of new anti-metastasis agents.

We are excited that Afnan Shahin has joined the research group from this year’s Chemical Biology and Medicinal Chemistry graduate student class. Welcome, Afnan!

Congratulations to Yelisbeth for presenting an award winning poster at the Eshelman School of Pharmacy Pharm Sci Retreat!

Feijun Wang’s efforts (over the past several years) investigating aryl activation for the electrochemical oxidation of amines have been published in Advanced Synthesis and Catalysis. We hope to have further applications of this method to share in the near future.

Charlie Zhang recently joined our team from Boston College. We are excited that you are contributing your talents to our drug discovery efforts and hope you enjoy the warmth & fun of the Chapel Hill area.

As we begin 2023, two new post-doctoral colleagues have recently joined our team. Welcome to Pawan Dhote and Feng Li! We are excited to work with you.